Do you consider SABR for oligometastatic disease in patients with TP53 germline mutation?  

In a patient with their second cancer, with oligometastatic disease, do the risks of RT related second malignancies outweigh the benefits?



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist
Great and very helpful answer! What’s the ra...
Radiation Oncologist at Case Western Reserve University/ University Hospitals Seidman Cancer Center
Good to hear from you Aaron!   Mayo clinic ...
Sign in or Register to read more